Literature DB >> 34076829

Clinicopathologic breast cancer characteristics: predictions using global textural features of the ipsilateral breast mammogram.

Ibrahem H Kanbayti1,2, William I D Rae3, Mark F McEntee3,4, Ziba Gandomkar3, Ernest U Ekpo3,5.   

Abstract

Radiomic features from mammograms have been shown to predict breast cancer (BC) risk; however, their contribution to BC characteristics has not yet been explored. This study included 184 women with BC between January 2012 and April 2017. A set of 33 global radiomic features were extracted from the ipsilateral breast mammogram. Associations between radiomic features and BC characteristics were investigated by univariate logistic regression analysis, and receiver-operating characteristic curve analysis was employed to evaluate the predictive performance of radiomic features. Histogram-based features (mean, 70th percentile, and 30th percentile) weakly differentiated progesterone status and tumor size (AUC range: 0.627-0.652, p ≤ 0.007). One gray level run length matrix (GLRLM)-based feature achieved an AUC of 0.68 in discriminating lymph-node status, and the fractal dimension achieved an AUC of 0.65 in predicting tumor size. After stratifying by age at BC diagnosis and baseline percent density (PD), the average predictive performance of the abovementioned features improved from 0.652 to 0.707 for baseline PD adjustment, and from 0.652 to 0.674 for age at BC diagnosis. Higher predictive performances were found for GLRLM-based features in predicting lymph-node status among younger women with high baseline PD (AUC range: 0.710-0.863), and for fractal features in predicting tumor size among patients with low PD (AUC: 0.704). Global radiomic features from the ipsilateral breast mammogram can predict lymph-node status and tumor size among certain categories of women and should be considered as a non-invasive tool for clinical decision-making in BC-affected women and for forecasting disease progression.

Entities:  

Keywords:  Breast cancer; Clinicopathologic characteristics; Global radiomic features; Mammography

Year:  2021        PMID: 34076829     DOI: 10.1007/s12194-021-00622-6

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  36 in total

Review 1.  Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer.

Authors:  E Nilüfer Güler
Journal:  Eur J Breast Health       Date:  2017-10-01

2.  Heterogeneity, histological features and DNA ploidy in oral carcinoma by image-based analysis.

Authors:  N Diwakar; M Sperandio; M Sherriff; A Brown; E W Odell
Journal:  Oral Oncol       Date:  2005-04       Impact factor: 5.337

Review 3.  Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Authors:  S Aebi; S Gelber; M Castiglione-Gertsch; R D Gelber; J Collins; B Thürlimann; C M Rudenstam; J Lindtner; D Crivellari; H Cortes-Funes; E Simoncini; I D Werner; A S Coates; A Goldhirsch
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

Review 4.  Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.

Authors:  Kathryn E Huber; Lisa A Carey; David E Wazer
Journal:  Semin Radiat Oncol       Date:  2009-10       Impact factor: 5.934

5.  The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Authors:  Michail Ignatiadis; Hatem A Azim; Christine Desmedt; Isabelle Veys; Denis Larsimont; Roberto Salgado; Maria B Lyng; Giuseppe Viale; Brian Leyland-Jones; Anita Giobbie-Hurder; Rosita Kammler; Patrizia Dell'Orto; Françoise Rothé; Ioanna Laïos; Henrik J Ditzel; Meredith M Regan; Martine Piccart; Stefan Michiels; Christos Sotiriou
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

6.  Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gary H Lyman; Mark R Somerfield; Linda D Bosserman; Cheryl L Perkins; Donald L Weaver; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2016-12-12       Impact factor: 44.544

7.  Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy.

Authors:  Faranak Aghaei; Maxine Tan; Alan B Hollingsworth; Wei Qian; Hong Liu; Bin Zheng
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

8.  Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.

Authors:  Ann H Partridge; Shari Gelber; Martine J Piccart-Gebhart; Florine Focant; Matthew Scullion; Eileen Holmes; Eric P Winer; Richard D Gelber
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

9.  Mammographic texture resemblance generalizes as an independent risk factor for breast cancer.

Authors:  Mads Nielsen; Celine M Vachon; Christopher G Scott; Konstantin Chernoff; Gopal Karemore; Nico Karssemeijer; Martin Lillholm; Morten A Karsdal
Journal:  Breast Cancer Res       Date:  2014-04-08       Impact factor: 6.466

10.  Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

Authors:  M Arnedos; A Nerurkar; P Osin; R A'Hern; I E Smith; M Dowsett
Journal:  Ann Oncol       Date:  2009-07-01       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.